Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Honeywell Aerospace Inc.HONA · Entity 1656 | Director | August 03, 2026 | August 05, 2026 |
| LOWES COMPANIES INCLOW · Entity 2896 | EVP, Chief Financial Officer | April 01, 2022 | April 05, 2022 |
| NIKE, Inc.NKE · Entity 2537 | EVP: CFO | September 01, 2026 | September 03, 2026 |
| PFIZER INCPFE · Entity 2863 | Chief Financial Officer & EVP | March 03, 2026 | March 05, 2026 |
| TAPESTRY, INC.TPR · Entity 2309 | Director | November 15, 2022 | November 16, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Honeywell Aerospace Inc.
Report date August 03, 2026 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 572 |
Reported balance
After 2026-08-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-03 · Grant · Acquired 572 · Balance 572 F1: Instrument converts to Issuer's Common Stock on a one-for-one basis. F2: The Restricted Stock Units shall vest on April 15, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Instrument converts to Issuer's Common Stock on a one-for-one basis.
F2: The Restricted Stock Units shall vest on April 15, 2027.
LOWES COMPANIES INC
Report date April 01, 2022 · Filed April 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 56,663 |
Ending reported balance
After 2022-04-01 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2022-04-01 · Exercise / conversion · Acquired 38,220 · Balance 72,543 F1: Each performance share unit represented a contingent right to receive one share of the Issuer's common stock upon the achievement of certain pre-established metrics over the three-year performance period ending at the end of fiscal 2021. Row 2 · 2022-04-01 · Tax withholding · Disposed 21,230 · Balance 51,313 F2: Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units and restricted shares granted on April 1, 2019. Row 3 · 2022-04-01 · Grant · Acquired 5,350 · Balance 56,663 F3: Restricted stock granted pursuant to 2006 Long-Term Incentive Plan. The shares will fully vest on April 1, 2025. |
| Performance Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-04-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-04-01 · Exercise / conversion · Disposed 38,220 · Balance 0 F4: At the vest date, the performance share units earned converted into an equivalent number of shares of the Issuer's common stock. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $202.40 · Expires 2032-04-01 | Direct | 18,265 |
Reported balance
After 2022-04-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-04-01 · Grant · Acquired 18,265 · Balance 18,265 F5: The option vests in three annual installments beginning on April 1, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Each performance share unit represented a contingent right to receive one share of the Issuer's common stock upon the achievement of certain pre-established metrics over the three-year performance period ending at the end of fiscal 2021.
F2: Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units and restricted shares granted on April 1, 2019.
F3: Restricted stock granted pursuant to 2006 Long-Term Incentive Plan. The shares will fully vest on April 1, 2025.
F4: At the vest date, the performance share units earned converted into an equivalent number of shares of the Issuer's common stock.
F5: The option vests in three annual installments beginning on April 1, 2023.
NIKE, Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table I · non-derivative | Direct | 71,234 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Grant · Acquired 71,234 · Balance 71,234 F1: Restricted Stock Units ("RSUs") granted under the NIKE, Inc. Stock Incentive Plan; 25% of the total number of RSUs granted vest on each of the first four anniversaries of the date of the grant. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.12 · Expires 2036-09-01 | Direct | 259,946 |
Reported balance
After 2026-09-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-01 · Grant · Acquired 259,946 · Balance 259,946 F2: Stock Option granted under the NIKE, Inc. Stock Incentive Plan; it becomes exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units ("RSUs") granted under the NIKE, Inc. Stock Incentive Plan; 25% of the total number of RSUs granted vest on each of the first four anniversaries of the date of the grant.
F2: Stock Option granted under the NIKE, Inc. Stock Incentive Plan; it becomes exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant.
PFIZER INC
Report date March 03, 2026 · Filed March 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $26.58 · Expires 2031-03-03 | Direct | 216,537 |
Reported balance
After 2026-03-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-03 · Grant · Acquired 216,537 · Balance 216,537 F1: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
TAPESTRY, INC.
Report date November 15, 2022 · Filed November 16, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,647 |
Reported balance
After 2022-11-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-11-15 · Grant · Acquired 2,430 · Balance 37,647 F1: All of the securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 15, 2023. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $34.98 · Expires 2032-11-15 | Direct | 6,822 |
Reported balance
After 2022-11-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-11-15 · Grant · Acquired 6,822 · Balance 6,822 F2: All of the securities acquired were issued under the Issuer's Stock Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: All of the securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 15, 2023.
F2: All of the securities acquired were issued under the Issuer's Stock Incentive Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CVS HEALTH Corp
Report date November 29, 2018 · Filed November 30, 2018
Section 16 reporting ended · disclosed 2018-11-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 402.9767 |
Reported balance
After 2018-11-29 transaction · row 1
1 source rowRow 1 · 2018-11-29 · Sale · Disposed 25,159 · Balance 402.9767 F1: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.72 and $80.54 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.72 and $80.54 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2018 Filed Feb 21, 2018 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | OtherStock Option · Derivative | 10,869 | $0.00 Strike: $78.05 | $0.00 |
DisclosureSEC source: 0001127602-18-007534 · form4.xml · derivative · entry 6 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,310 Underlying: Common Stock · 10,869 shares Expires 2024-04-03 F3 · shares: Represents stock options that are being held in constructive trust for the sole benefit of the reporting person's ex-spouse, effective as of the end of the 90-day waiting period under a divorce decree, which waiting period ended on or about February 20, 2018. The stock options held in trust for the ex-spouse are no longer beneficially owned by the reporting person. F7 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | OtherStock Option · Derivative | 22,716 | $0.00 Strike: $104.82 | $0.00 |
DisclosureSEC source: 0001127602-18-007534 · form4.xml · derivative · entry 5 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,980 Underlying: Common Stock · 22,716 shares Expires 2023-04-01 F3 · shares: Represents stock options that are being held in constructive trust for the sole benefit of the reporting person's ex-spouse, effective as of the end of the 90-day waiting period under a divorce decree, which waiting period ended on or about February 20, 2018. The stock options held in trust for the ex-spouse are no longer beneficially owned by the reporting person. F6 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | OtherStock Option · Derivative | 25,540 | $0.00 Strike: $102.26 | $0.00 |
DisclosureSEC source: 0001127602-18-007534 · form4.xml · derivative · entry 4 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,382 Underlying: Common Stock · 25,540 shares Expires 2022-04-01 F3 · shares: Represents stock options that are being held in constructive trust for the sole benefit of the reporting person's ex-spouse, effective as of the end of the 90-day waiting period under a divorce decree, which waiting period ended on or about February 20, 2018. The stock options held in trust for the ex-spouse are no longer beneficially owned by the reporting person. F5 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | OtherStock Option · Derivative | 30,325 | $0.00 Strike: $74.29 | $0.00 |
DisclosureSEC source: 0001127602-18-007534 · form4.xml · derivative · entry 3 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,618 Underlying: Common Stock · 30,325 shares Expires 2021-04-01 F3 · shares: Represents stock options that are being held in constructive trust for the sole benefit of the reporting person's ex-spouse, effective as of the end of the 90-day waiting period under a divorce decree, which waiting period ended on or about February 20, 2018. The stock options held in trust for the ex-spouse are no longer beneficially owned by the reporting person. F4 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | OtherCommon Stock | 18,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-007534 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,400.99 F2 · shares: Represents shares that have been transferred to the reporting person's ex-spouse pursuant to a divorce decree on various dates during the 90-day waiting period under the decree that ended on or about February 20, 2018. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | OtherCommon Stock (restricted) | 38,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-007534 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,041 F1 · shares: Represents restricted stock units (RSUs) that are being held in constructive trust for the sole benefit of the reporting person's ex-spouse, effective as of the end of the 90-day waiting period under a divorce decree, which waiting period ended on or about February 20, 2018. The RSUs held in trust for the ex-spouse are no longer beneficially owned by the reporting person. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 23:44 UTC | TAPESTRY, INC. COH · Entity 2309 | GrantStock Option · Derivative | 9,338 | $0.00 Strike: $40.16 | $0.00 |
DisclosureSEC source: 0001225208-17-017262 · doc4.xml · derivative · entry 2 Denton David M · CIK 0001428718 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,338 Underlying: Common Stock · 9,338 shares Expires 2027-11-09 F2 · security: All of the securities acquired were issued under the Issuer's Stock Incentive Plan. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 23:44 UTC | TAPESTRY, INC. COH · Entity 2309 | GrantCommon Stock | 1,868 | $40.16 | $75,018.88 |
DisclosureSEC source: 0001225208-17-017262 · doc4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,564 F1 · security: All of the securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 9, 2018. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 21:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 108,183 | $0.00 Strike: $54.53 | $0.00 |
DisclosureSEC source: 0001127602-17-027344 · form4.xml · derivative · entry 7 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 108,183 shares Expires 2020-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 21:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 108,183 | $79.62 | $8,613,530.46 |
DisclosureSEC source: 0001127602-17-027344 · form4.xml · nonDerivative · entry 4 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,056.399 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F4 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.33 and $80.00 per share. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 21:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 108,183 | $54.53 | $5,899,218.99 |
DisclosureSEC source: 0001127602-17-027344 · form4.xml · nonDerivative · entry 3 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,239.399 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 21:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 105,040 | $79.68 | $8,369,587.20 |
DisclosureSEC source: 0001127602-17-027344 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,056.399 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.35 and $80.00 per share. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 21:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 23,855 | $79.61 | $1,899,096.55 |
DisclosureSEC source: 0001127602-17-027344 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,096.399 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.33 and $80.00 per share. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 20:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 107,178 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-17-021306 · form4.xml · derivative · entry 9 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 107,178 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 20:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 110,912 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-17-021306 · form4.xml · derivative · entry 8 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 110,912 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 20:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 12,420 | $0.00 Strike: $40.28 | $0.00 |
DisclosureSEC source: 0001127602-17-021306 · form4.xml · derivative · entry 7 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,420 shares Expires 2018-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 3/5/2011. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 20:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 230,510 | $80.00 | $18,440,800.00 |
DisclosureSEC source: 0001127602-17-021306 · form4.xml · nonDerivative · entry 4 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,562.8314 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 20:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 107,178 | $34.96 | $3,746,942.88 |
DisclosureSEC source: 0001127602-17-021306 · form4.xml · nonDerivative · entry 3 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,072.8314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 20:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 110,912 | $45.07 | $4,998,803.84 |
DisclosureSEC source: 0001127602-17-021306 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,894.8314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 20:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 12,420 | $40.28 | $500,277.60 |
DisclosureSEC source: 0001127602-17-021306 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,982.8314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 100,179 | $78.05 Strike: $78.05 | $7,818,970.95 |
DisclosureSEC source: 0001127602-17-014057 · form4.xml · derivative · entry 5 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,179 Underlying: Common Stock · 100,179 shares Expires 2024-04-03 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 12,812 | $78.05 | $999,976.60 |
DisclosureSEC source: 0001127602-17-014057 · form4.xml · nonDerivative · entry 3 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,877 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
| April 02, 2017 Filed Apr 4, 2017 21:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 6,649 | $78.50 | $521,946.50 |
DisclosureSEC source: 0001127602-17-014057 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,562.8314 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 21:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,420 | $78.50 | $189,970.00 |
DisclosureSEC source: 0001127602-17-014057 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,211.8314 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 20:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 95,618 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-17-011434 · form4.xml · derivative · entry 5 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 95,618 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 20:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 95,618 | $80.68 | $7,714,460.24 |
DisclosureSEC source: 0001127602-17-011434 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,716.8314 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $80.40 and $81.00 per share. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 20:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 95,618 | $36.23 | $3,464,240.14 |
DisclosureSEC source: 0001127602-17-011434 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,334.8314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 7,506 | $80.58 | $604,833.48 |
DisclosureSEC source: 0001127602-17-009779 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,716.8314 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Registrant's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 18,615 | $80.58 | $1,499,996.70 |
DisclosureSEC source: 0001127602-17-009779 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,222.8314 F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 21:51 UTC | TAPESTRY, INC. COH · Entity 2309 | GrantStock Option · Derivative | 11,284 | $0.00 Strike: $36.72 | $0.00 |
DisclosureSEC source: 0001225208-16-041681 · doc4.xml · derivative · entry 2 Denton David M · CIK 0001428718 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,284 Underlying: Common Stock · 11,284 shares Expires 2026-11-10 F2 · security: These securities were issued under the Amended and Restated Coach, Inc. 2010 Stock Incentive Plan (Amended and Restated as of September 23, 2016) of the Issuer. F3 · derivative.exercise_price: These securities will convert on a 1-for-1 basis into shares of the issuer's common stock. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 21:51 UTC | TAPESTRY, INC. COH · Entity 2309 | GrantCommon Stock | 2,042 | $36.72 | $74,982.24 |
DisclosureSEC source: 0001225208-16-041681 · doc4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,628 F1 · security: All of the securities acquired were received in the form of unvested restricted stock units issued under the Amended and Restated Coach, Inc. 2010 Stock Incentive Plan (Amended and Restated as of September 23, 2016) of the Issuer. These securities will vest on November 10, 2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 71,696 | $104.82 Strike: $104.82 | $7,515,174.72 |
DisclosureSEC source: 0001127602-16-048882 · form4.xml · derivative · entry 4 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,696 Underlying: Common Stock · 71,696 shares Expires 2023-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 9,540 | $104.82 | $999,982.80 |
DisclosureSEC source: 0001127602-16-048882 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,980 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 12,902 | $104.82 | $1,352,387.64 |
DisclosureSEC source: 0001127602-16-048882 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,266.1391 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 16,748 | $97.17 | $1,627,403.16 |
DisclosureSEC source: 0001127602-16-044575 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,257.1391 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| April 02, 2015 Filed Apr 3, 2015 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 6,648 | $102.71 | $682,816.08 |
DisclosureSEC source: 0001127602-15-013954 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,187.3964 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 59,922 | $102.26 Strike: $102.26 | $6,127,623.72 |
DisclosureSEC source: 0001127602-15-013954 · form4.xml · derivative · entry 4 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,922 Underlying: Common Stock · 59,922 shares Expires 2022-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 8,556 | $102.26 | $874,936.56 |
DisclosureSEC source: 0001127602-15-013954 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,351 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 21:59 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 18,051 | $103.87 | $1,874,957.37 |
DisclosureSEC source: 0001127602-15-009631 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,968.3964 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| August 22, 2014 Filed Feb 10, 2015 21:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 380 | $79.24 | $30,111.20 |
DisclosureSEC source: 0001127602-15-005276 · form5.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,917.3964 Read SEC document |
| July 01, 2014 Filed Jul 3, 2014 20:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 48,178 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-14-022890 · form4.xml · derivative · entry 7 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,178 shares Expires 2016-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2010. Read SEC document |
| July 01, 2014 Filed Jul 3, 2014 20:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 26,811 | $0.00 Strike: $41.17 | $0.00 |
DisclosureSEC source: 0001127602-14-022890 · form4.xml · derivative · entry 6 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,811 shares Expires 2015-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2009. Read SEC document |
| July 01, 2014 Filed Jul 3, 2014 20:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 74,989 | $75.88 | $5,690,165.32 |
DisclosureSEC source: 0001127602-14-022890 · form4.xml · nonDerivative · entry 3 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,883.7692 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $75.46 and $76.16 per share. Read SEC document |
| July 01, 2014 Filed Jul 3, 2014 20:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 48,178 | $28.10 | $1,353,801.80 |
DisclosureSEC source: 0001127602-14-022890 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,872.7692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2014 Filed Jul 3, 2014 20:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 26,811 | $41.17 | $1,103,808.87 |
DisclosureSEC source: 0001127602-14-022890 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,694.7692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 62,943 | $74.29 Strike: $74.29 | $4,676,035.47 |
DisclosureSEC source: 0001127602-14-014003 · form4.xml · derivative · entry 5 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,943 Underlying: Common Stock · 62,943 shares Expires 2021-04-01 F4 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 100,000 | $74.29 | $7,429,000.00 |
DisclosureSEC source: 0001127602-14-014003 · form4.xml · nonDerivative · entry 3 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,662 F3 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse on 4/1/2021. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 10,095 | $74.29 | $749,957.55 |
DisclosureSEC source: 0001127602-14-014003 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,662 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2017 and 50% on 4/1/2019. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 6,857 | $74.29 | $509,406.53 |
DisclosureSEC source: 0001127602-14-014003 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,883.7692 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 21,331 | $70.32 | $1,499,995.92 |
DisclosureSEC source: 0001127602-14-007471 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,438.7692 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.